Congo vs Djibouti: Access to anti-retroviral drugs, male
Congo
40.0%
in 2024
Djibouti
28.0%
in 2024
Congo rank
131st
Djibouti rank
133rd
Access to anti-retroviral drugs, male over time
- Congo
- Djibouti
How they compare
Congo currently reports 40.0% against 28.0% in Djibouti, a difference of 12.0%.
That makes Congo's figure about 1.4 times Djibouti's.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Djibouti ahead.
Congo ranks 131st and Djibouti ranks 133rd of 141 countries.
Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Djibouti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.4% | 1.8% | 3.7% | Congo |
| 2010s | 20.4% | 13.0% | 7.4% | Congo |
| 2020s | 31.8% | 23.2% | 8.6% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Congo or Djibouti?
- Congo, at 40.0% against 28.0% in Djibouti as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Congo and Djibouti?
- 12.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Djibouti?
- 24 years are reported by both, from 2000 to 2024.
- How do Congo and Djibouti rank globally for access to anti-retroviral drugs, male?
- Congo ranks 131st and Djibouti ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.